JP2021500922A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021500922A5 JP2021500922A5 JP2020542710A JP2020542710A JP2021500922A5 JP 2021500922 A5 JP2021500922 A5 JP 2021500922A5 JP 2020542710 A JP2020542710 A JP 2020542710A JP 2020542710 A JP2020542710 A JP 2020542710A JP 2021500922 A5 JP2021500922 A5 JP 2021500922A5
- Authority
- JP
- Japan
- Prior art keywords
- promoter
- cfh
- item
- aav vector
- aav
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000013607 AAV vector Substances 0.000 claims description 61
- 102100035432 Complement factor H Human genes 0.000 claims description 47
- 101000737574 Homo sapiens Complement factor H Proteins 0.000 claims description 47
- 239000000203 mixture Substances 0.000 claims description 43
- 239000002773 nucleotide Substances 0.000 claims description 42
- 125000003729 nucleotide group Chemical group 0.000 claims description 42
- 239000012634 fragment Substances 0.000 claims description 41
- 239000013598 vector Substances 0.000 claims description 38
- 210000004027 cell Anatomy 0.000 claims description 34
- 210000003583 retinal pigment epithelium Anatomy 0.000 claims description 14
- 230000035772 mutation Effects 0.000 claims description 12
- 210000001525 retina Anatomy 0.000 claims description 10
- 230000000694 effects Effects 0.000 claims description 7
- 206010064930 age-related macular degeneration Diseases 0.000 claims description 6
- 208000002780 macular degeneration Diseases 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 208000003098 Ganglion Cysts Diseases 0.000 claims description 5
- 206010025421 Macule Diseases 0.000 claims description 5
- 208000005400 Synovial Cyst Diseases 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 241000702423 Adeno-associated virus - 2 Species 0.000 claims description 3
- 101150030967 CFH gene Proteins 0.000 claims description 3
- 101150091459 CFI gene Proteins 0.000 claims description 3
- 102100035431 Complement factor I Human genes 0.000 claims description 3
- 102220599936 Disks large-associated protein 5_G69E_mutation Human genes 0.000 claims description 3
- 102220612381 Mitogen-activated protein kinase kinase kinase 1_S58A_mutation Human genes 0.000 claims description 3
- 210000004126 nerve fiber Anatomy 0.000 claims description 3
- 102200027734 rs118092776 Human genes 0.000 claims description 3
- 102200031710 rs121913059 Human genes 0.000 claims description 3
- 102200031950 rs121913062 Human genes 0.000 claims description 3
- 102220130078 rs143237092 Human genes 0.000 claims description 3
- 102200147378 rs398123072 Human genes 0.000 claims description 3
- 102220047868 rs570523689 Human genes 0.000 claims description 3
- 102200037607 rs771019366 Human genes 0.000 claims description 3
- 230000003612 virological effect Effects 0.000 claims description 3
- 102100040132 Complement factor H-related protein 1 Human genes 0.000 claims description 2
- 241000702421 Dependoparvovirus Species 0.000 claims description 2
- 101000890732 Homo sapiens Complement factor H-related protein 1 Proteins 0.000 claims description 2
- 102100021244 Integral membrane protein GPR180 Human genes 0.000 claims description 2
- 230000015556 catabolic process Effects 0.000 claims description 2
- 230000024203 complement activation Effects 0.000 claims description 2
- 238000006731 degradation reaction Methods 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 101001031607 Homo sapiens Four and a half LIM domains protein 1 Proteins 0.000 claims 5
- 102000057125 human FHL1 Human genes 0.000 claims 5
- 239000002245 particle Substances 0.000 claims 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 2
- 102000010175 Opsin Human genes 0.000 claims 2
- 108050001704 Opsin Proteins 0.000 claims 2
- 201000007737 Retinal degeneration Diseases 0.000 claims 2
- 239000008187 granular material Substances 0.000 claims 2
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 claims 1
- 241001164825 Adeno-associated virus - 8 Species 0.000 claims 1
- 102100022794 Bestrophin-1 Human genes 0.000 claims 1
- 108090000565 Capsid Proteins Proteins 0.000 claims 1
- 102000014914 Carrier Proteins Human genes 0.000 claims 1
- 102100023321 Ceruloplasmin Human genes 0.000 claims 1
- 101001031598 Dictyostelium discoideum Probable serine/threonine-protein kinase fhkC Proteins 0.000 claims 1
- 101100118093 Drosophila melanogaster eEF1alpha2 gene Proteins 0.000 claims 1
- 108091006027 G proteins Proteins 0.000 claims 1
- 102000030782 GTP binding Human genes 0.000 claims 1
- 108091000058 GTP-Binding Proteins 0.000 claims 1
- 102100022758 Glutamate receptor ionotropic, kainate 2 Human genes 0.000 claims 1
- 101710112360 Glutamate receptor ionotropic, kainate 2 Proteins 0.000 claims 1
- 102100030386 Granzyme A Human genes 0.000 claims 1
- 101000903449 Homo sapiens Bestrophin-1 Proteins 0.000 claims 1
- 101001009599 Homo sapiens Granzyme A Proteins 0.000 claims 1
- 101000597428 Homo sapiens Nucleoredoxin-like protein 1 Proteins 0.000 claims 1
- 101000594760 Homo sapiens Nucleoredoxin-like protein 2 Proteins 0.000 claims 1
- 101001078886 Homo sapiens Retinaldehyde-binding protein 1 Proteins 0.000 claims 1
- 101000829506 Homo sapiens Rhodopsin kinase GRK1 Proteins 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 102100035399 Nucleoredoxin-like protein 1 Human genes 0.000 claims 1
- 102100036205 Nucleoredoxin-like protein 2 Human genes 0.000 claims 1
- 102100029533 Photoreceptor-specific nuclear receptor Human genes 0.000 claims 1
- 101710164507 Photoreceptor-specific nuclear receptor Proteins 0.000 claims 1
- 102100028001 Retinaldehyde-binding protein 1 Human genes 0.000 claims 1
- 102100040756 Rhodopsin Human genes 0.000 claims 1
- 108090000820 Rhodopsin Proteins 0.000 claims 1
- 102100023742 Rhodopsin kinase GRK1 Human genes 0.000 claims 1
- 102000005801 Rod Opsins Human genes 0.000 claims 1
- 108010005063 Rod Opsins Proteins 0.000 claims 1
- 102000006612 Transducin Human genes 0.000 claims 1
- 108010087042 Transducin Proteins 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 150000001413 amino acids Chemical group 0.000 claims 1
- 108091008324 binding proteins Proteins 0.000 claims 1
- 210000003161 choroid Anatomy 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 230000002503 metabolic effect Effects 0.000 claims 1
- 150000007523 nucleic acids Chemical group 0.000 claims 1
- 210000000608 photoreceptor cell Anatomy 0.000 claims 1
- 102000005962 receptors Human genes 0.000 claims 1
- 108020003175 receptors Proteins 0.000 claims 1
- 230000004258 retinal degeneration Effects 0.000 claims 1
- 108010079094 short-wavelength opsin Proteins 0.000 claims 1
- 238000000034 method Methods 0.000 description 24
- 108090001126 Furin Proteins 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 239000004365 Protease Substances 0.000 description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 4
- 210000003494 hepatocyte Anatomy 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 102000040430 polynucleotide Human genes 0.000 description 4
- 239000002157 polynucleotide Substances 0.000 description 4
- 108091033319 polynucleotide Proteins 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- 208000017442 Retinal disease Diseases 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000002987 choroid plexus Anatomy 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 108010053085 Complement Factor H Proteins 0.000 description 1
- 102000016550 Complement Factor H Human genes 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 210000001775 bruch membrane Anatomy 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762574814P | 2017-10-20 | 2017-10-20 | |
| US62/574,814 | 2017-10-20 | ||
| PCT/US2018/056709 WO2019079718A1 (en) | 2017-10-20 | 2018-10-19 | COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021500922A JP2021500922A (ja) | 2021-01-14 |
| JP2021500922A5 true JP2021500922A5 (OSRAM) | 2021-11-25 |
Family
ID=66174265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542710A Withdrawn JP2021500922A (ja) | 2017-10-20 | 2018-10-19 | 加齢黄斑変性を処置するための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210188927A1 (OSRAM) |
| EP (1) | EP3697920A4 (OSRAM) |
| JP (1) | JP2021500922A (OSRAM) |
| CN (1) | CN111788311A (OSRAM) |
| AU (1) | AU2018351491A1 (OSRAM) |
| CA (1) | CA3079553A1 (OSRAM) |
| WO (1) | WO2019079718A1 (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3106838A1 (en) * | 2018-07-20 | 2020-01-23 | University Of Utah Research Foundation | Gene therapy for macular degeneration |
| WO2020086735A1 (en) * | 2018-10-23 | 2020-04-30 | Gemini Therapeutics Inc. | Compositions and methods for treating age-related macular degeneration and other diseases |
| GB201821089D0 (en) * | 2018-12-21 | 2019-02-06 | Gyroscope Therapeutics Ltd | Codon-optimised complement factor I |
| CN115175706A (zh) * | 2019-10-22 | 2022-10-11 | 应用遗传科技公司 | 用于治疗年龄相关性黄斑变性及其它眼部疾病和病症的腺伴随病毒(aav)载体 |
| WO2021081395A1 (en) * | 2019-10-23 | 2021-04-29 | Gemini Therapeutics Inc. | Methods for treating patients having cfh mutations with recombinant cfh proteins |
| CA3182800A1 (en) | 2020-06-14 | 2021-12-23 | Vertex Pharmaceuticals Inc. | Complement factor i-related compositions and methods |
| EP4229076A1 (en) * | 2020-10-16 | 2023-08-23 | Gyroscope Therapeutics Limited | Nucleic acid encoding an anti-vegf entity and a negative complement regulator and uses thereof for the treatment of age-related macular degeneration |
| WO2022094340A1 (en) * | 2020-10-30 | 2022-05-05 | Gemini Therapeutics Sub, Inc. | Methods for treating inflammatory ocular diseases with complement factor h |
| CN115786308B (zh) * | 2022-11-24 | 2024-05-31 | 江苏海洋大学 | 一种提高右旋糖酐酶热稳定性的方法及突变体 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005333845A (ja) * | 2004-05-25 | 2005-12-08 | Tokyoto Igaku Kenkyu Kiko | ミトコンドリア局在型ＤｓＲｅｄ２及びＥＣＦＰ発現ベクター |
| NZ595305A (en) * | 2005-02-14 | 2013-06-28 | Univ Iowa Res Found | Methods and reagents for treatment and diagnosis of age-related macular degeneration |
| AU2016326627B2 (en) * | 2015-09-24 | 2022-12-15 | The Trustees Of The University Of Pennsylvania | Composition and method for treating complement-mediated disease |
| GB201519086D0 (en) * | 2015-10-28 | 2015-12-09 | Syncona Partners Llp | Gene Therapy |
-
2018
- 2018-10-19 AU AU2018351491A patent/AU2018351491A1/en not_active Abandoned
- 2018-10-19 US US16/757,268 patent/US20210188927A1/en not_active Abandoned
- 2018-10-19 JP JP2020542710A patent/JP2021500922A/ja not_active Withdrawn
- 2018-10-19 EP EP18869436.8A patent/EP3697920A4/en not_active Withdrawn
- 2018-10-19 CN CN201880078342.1A patent/CN111788311A/zh active Pending
- 2018-10-19 CA CA3079553A patent/CA3079553A1/en not_active Abandoned
- 2018-10-19 WO PCT/US2018/056709 patent/WO2019079718A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021500922A5 (OSRAM) | ||
| JP2022141670A5 (OSRAM) | ||
| JP2021503914A5 (OSRAM) | ||
| US10413598B2 (en) | Factor IX gene therapy | |
| JP2018508519A5 (OSRAM) | ||
| JP2022091764A (ja) | 血管性浮腫の治療としてのｃ１ｅｉのアデノ随伴ウイルス介在性送達 | |
| RU2018142768A (ru) | Варианты капсидов аденоассоциированного вируса и способы их применения | |
| JP2023088902A5 (OSRAM) | ||
| JP7654562B2 (ja) | 線維芽細胞増殖因子２３関連低リン血症性疾患の遺伝子療法 | |
| KR20190020745A (ko) | Abc4a를 발현시키기 위한 이중 중첩 아데노-관련 바이러스 벡터 시스템 | |
| IL262852B1 (en) | Treatment of complement-mediated disorders | |
| JP2020512822A5 (OSRAM) | ||
| JP2019524090A5 (OSRAM) | ||
| JPWO2020069461A5 (OSRAM) | ||
| KR20190038583A (ko) | 알데히드 데히드로게나제 결핍의 치료를 위한 유전자 요법 | |
| JP2018509154A5 (OSRAM) | ||
| US11744851B2 (en) | Enhancing AAV-mediated transduction of ocular tissues with hyaluronic acid | |
| CN118853712A (zh) | 编码抗vegf蛋白的核酸、多核苷酸表达盒及重组腺相关病毒 | |
| AU2019206314A1 (en) | Compositions and methods for treating retinal disorders | |
| IL312657A (en) | Codon-optimised complement factor i | |
| WO2015148454A1 (en) | Optimized and modified factor viii genes for gene therapy | |
| JP2023526892A (ja) | バルデー・ビードル症候群の遺伝子治療 | |
| CN114126667A (zh) | 使用糖苷水解酶的基因疗法载体向视网膜细胞的改进递送 | |
| CN117947041A (zh) | 编码重组补体因子h多肽的核酸分子及用途 | |
| JPWO2021243085A5 (OSRAM) |